These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 25854266)

  • 21. [Role of the morphogenetic proteins FGF-23 and Klotho and the glycoprotein sclerostin in the assessment of the risk of cardiovascular diseases and the prognosis of chronic kidney disease].
    Milovanova LY; Milovanov YS; Kudryavtseva DV; Markina MM; Milovanova SY; Kozlovskaya LV; Lebedeva MV; Beketov VD; Moiseev SV; Mukhin NA; Fomin VV; Svistunov AA
    Ter Arkh; 2015; 87(6):10-16. PubMed ID: 26281189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum sclerostin and adverse outcomes in nondialyzed chronic kidney disease patients.
    Kanbay M; Siriopol D; Saglam M; Kurt YG; Gok M; Cetinkaya H; Karaman M; Unal HU; Oguz Y; Sari S; Eyileten T; Goldsmith D; Vural A; Veisa G; Covic A; Yilmaz MI
    J Clin Endocrinol Metab; 2014 Oct; 99(10):E1854-61. PubMed ID: 25057883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical significance of serum levels of osteoproteherin and sclerostin in assessment of vascular calcification in chronic kidney disease stage 3-5].
    Dzgoeva FU; Remizov OV; Botcieva VK; Goloeva VG; Malakhova NG; Ikoeva ZR
    Ter Arkh; 2022 Aug; 94(6):731-737. PubMed ID: 36286849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating levels of sclerostin but not DKK1 associate with laboratory parameters of CKD-MBD.
    Behets GJ; Viaene L; Meijers B; Blocki F; Brandenburg VM; Verhulst A; D'Haese PC; Evenepoel P
    PLoS One; 2017; 12(5):e0176411. PubMed ID: 28493902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of aromatase inhibition on serum levels of sclerostin and dickkopf-1, bone turnover markers and bone mineral density in women with breast cancer.
    Kyvernitakis I; Rachner TD; Urbschat A; Hars O; Hofbauer LC; Hadji P
    J Cancer Res Clin Oncol; 2014 Oct; 140(10):1671-80. PubMed ID: 24903965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum uric acid is associated with coronary artery calcification in early chronic kidney disease: a cross-sectional study.
    Han M; Kim H; Kim HJ; Kang E; Kim YS; Choi KH; Kim SW; Ahn C; Oh KH
    BMC Nephrol; 2021 Jul; 22(1):247. PubMed ID: 34218791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal elimination of sclerostin increases with declining kidney function.
    Cejka D; Marculescu R; Kozakowski N; Plischke M; Reiter T; Gessl A; Haas M
    J Clin Endocrinol Metab; 2014 Jan; 99(1):248-55. PubMed ID: 24187403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and biological determinants of sclerostin plasma concentration in hemodialysis patients.
    Delanaye P; Krzesinski JM; Warling X; Moonen M; Smelten N; Médart L; Bruyère O; Reginster JY; Pottel H; Cavalier E
    Nephron Clin Pract; 2014; 128(1-2):127-34. PubMed ID: 25377055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pericardial fat is associated with coronary artery calcification in non-dialysis dependent chronic kidney disease patients.
    Harada PH; Canziani ME; Lima LM; Kamimura M; Rochitte CE; Lemos MM; Cuppari L; Kalil Filho R; Draibe SA; Santos RD
    PLoS One; 2014; 9(12):e114358. PubMed ID: 25479288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating levels of dickkopf-1, osteoprotegerin and sclerostin are higher in old compared with young men and women and positively associated with whole-body bone mineral density in older adults.
    Coulson J; Bagley L; Barnouin Y; Bradburn S; Butler-Browne G; Gapeyeva H; Hogrel JY; Maden-Wilkinson T; Maier AB; Meskers C; Murgatroyd C; Narici M; Pääsuke M; Sassano L; Sipilä S; Al-Shanti N; Stenroth L; Jones DA; McPhee JS
    Osteoporos Int; 2017 Sep; 28(9):2683-2689. PubMed ID: 28585053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High Parathyroid Hormone Level and Osteoporosis Predict Progression of Coronary Artery Calcification in Patients on Dialysis.
    Malluche HH; Blomquist G; Monier-Faugere MC; Cantor TL; Davenport DL
    J Am Soc Nephrol; 2015 Oct; 26(10):2534-44. PubMed ID: 25838468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the association of Wnt signaling with coronary artery calcification in patients on dialysis with severe secondary hyperparathyroidism.
    Ho TY; Chen NC; Hsu CY; Huang CW; Lee PT; Chou KJ; Fang HC; Chen CL
    BMC Nephrol; 2019 Sep; 20(1):345. PubMed ID: 31477034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Osteoporosis and vascular calcification in rheumatoid arthritis - the role of osteoprotegerin and sclerostin].
    Krajewska-Włodarczyk M; Stompór T
    Pol Merkur Lekarski; 2017 Jul; 43(253):41-47. PubMed ID: 28805201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum osteoprotegerin as a screening tool for coronary artery calcification score in diabetic pre-dialysis patients.
    Mikami S; Hamano T; Fujii N; Nagasawa Y; Isaka Y; Moriyama T; Matsuhisa M; Ito T; Imai E; Hori M
    Hypertens Res; 2008 Jun; 31(6):1163-70. PubMed ID: 18716364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum bone markers in ROD patients across the spectrum of decreases in GFR: Activin A increases before all other markers
.
    Lima F; Mawad H; El-Husseini AA; Davenport DL; Malluche HH
    Clin Nephrol; 2019 Apr; 91(4):222-230. PubMed ID: 30862350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for progression of coronary artery calcification in patients with chronic kidney disease: The CRIC study.
    Bundy JD; Chen J; Yang W; Budoff M; Go AS; Grunwald JE; Kallem RR; Post WS; Reilly MP; Ricardo AC; Rosas SE; Zhang X; He J;
    Atherosclerosis; 2018 Apr; 271():53-60. PubMed ID: 29459266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relationships between serum sclerostin, bone mineral density, and vascular calcification in rheumatoid arthritis.
    Paccou J; Mentaverri R; Renard C; Liabeuf S; Fardellone P; Massy ZA; Brazier M; Kamel S
    J Clin Endocrinol Metab; 2014 Dec; 99(12):4740-8. PubMed ID: 25222755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum sclerostin values are associated with abdominal aortic calcification and predict cardiovascular events in patients with chronic kidney disease stages 3-5D.
    Wang XR; Yuan L; Zhang JJ; Hao L; Wang DG
    Nephrology (Carlton); 2017 Apr; 22(4):286-292. PubMed ID: 27165564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relationship between inhibitors of the Wnt signalling pathway (Dickkopf-1(DKK1) and sclerostin), bone mineral density, vascular calcification and arterial stiffness in post-menopausal women.
    Hampson G; Edwards S; Conroy S; Blake GM; Fogelman I; Frost ML
    Bone; 2013 Sep; 56(1):42-7. PubMed ID: 23702386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of BMI on cardiovascular events, renal function, and coronary artery calcification.
    Russo D; Morrone LF; Errichiello C; De Gregorio MG; Imbriaco M; Battaglia Y; Russo L; Andreucci M; Di Iorio BR
    Blood Purif; 2014; 38(1):1-6. PubMed ID: 25196674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.